Oruka Therapeutics ORKA
Agarwal Arjun (Officer) plans to sell 28,588 ORKA shares, about $2.5M
- Form
- 144
- Filed
- Importance
- Routine
- Accession
- 0001950047-26-007037
- Approximate sale date: Jul 13, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Shares acquired by: Exercise of Stock Options
- 10b5-1 plan adopted: Feb 11, 2026
All of Agarwal Arjun's insider filings, holdings and planned sales
Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):
- Sold 3,743 shares at $84.26 on Jul 13, 2026 · Form 4
- Sold 5,656 shares at $84.9 on Jul 13, 2026 · Form 4
- Sold 2,100 shares at $104.67 on Aug 13, 2026 · Form 4
- Sold 2,132 shares at $105.57 on Aug 13, 2026 · Form 4
- Sold 1,268 shares at $106.63 on Aug 13, 2026 · Form 4
- Sold 2,142 shares at $107.71 on Aug 13, 2026 · Form 4
- Sold 2,358 shares at $108.46 on Aug 13, 2026 · Form 4
- Sold 3,000 shares at $91.11 on Sep 11, 2026 · Form 4
- Sold 4,051 shares at $92.41 on Sep 11, 2026 · Form 4
- Sold 2,208 shares at $93.26 on Sep 11, 2026 · Form 4
- Sold 200 shares at $94.02 on Sep 11, 2026 · Form 4
Written from the Form 144 on EDGAR. Check the filing before you rely on it.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- CytomX Therapeutics CTMX public float $372M, Jun 30, 2025
- Cronos Group CRON public float $380M, Jun 30, 2025
- REGENXBIO RGNX public float $385M, Jun 30, 2025
- Capricor Therapeutics CAPR public float $399M, Jun 30, 2025
- Cryoport CYRX public float $400M, Jun 30, 2025
